Royal Arc Ele. (ROYALARC)
CyclicalScore breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹153.1 |
| Market Cap | ₹176.49 Cr |
| P/E Ratio | 16.73 |
| ROCE | 22.18% |
| ROE | —% |
| Dividend Yield | 0.31% |
| Profit Growth | 37.26% |
| Debt/Equity | — |
| Sales Growth | 15.52% |
| Promoter Holding | 72.96% |
| 52-Week Range | ₹136 — ₹197 |
| Sector | Industrial Products |
Strengths
- Profit growth of 37.26% outpaces sales growth of 15.52%, showing operating leverage.
- ROCE of 22.18% indicates efficient use of capital.
- Piotroski F-Score of 7/9 suggests solid profitability and improving financial health.
- Promoter holding of 72.96% aligns management interests with shareholders.
- PEG of 0.63 and P/E of 16.73 are reasonable if growth persists.
Concerns
- No disclosed book value, debt-equity, or ROE, making balance sheet risk hard to assess.
- Latest quarter net profit of ₹4 Cr on sales of ₹53 Cr implies a thin net margin of roughly 7.5%.
- Dividend yield of only 0.31% provides little income cushion.
- Electrodes and refractories are cyclical; current profit growth may not be durable.
AI Analysis
Looking at Royal Arc Ele, I first notice the price. At ₹153.10, the market values it at ₹176 Cr. That works out to a P/E of 16.73. For a company growing profits at 37.26%, that is not an expensive price. The PEG ratio of 0.63 suggests the market is not paying up for growth. But I have learned to be careful with cyclical businesses. Electrodes and refractories live or die with steel and industrial activity. What looks like growth can simply be the upturn in a cycle. Still, the figures I can check are decent. Return on capital employed is 22.18%, which is a solid use of shareholder money. The Piotroski F-Score of 7/9 is encouraging; it tells me profitability and operating efficiency are improving. Promoter holding of 72.96% means those who run the company own most of it; in a small company, that is comforting. What bothers me is what is not shown. There is no book value, no debt-to-equity, no return on equity. For a disciplined investor, an unknown balance sheet is a bigger risk than a high P/E. I cannot judge financial strength without that information. The dividend yield of 0.31% is negligible; I am not being paid to wait. In the latest quarter, sales were ₹53 Cr and profit ₹4 Cr, so the net margin is roughly 7.5%. That is thin for an industrial business. If this is a fast grower, the price may be reasonable. But my honest read is that Royal Arc is a cyclical, small-cap industrial. I would wait for more balance sheet disclosure and a wider margin of safety. Ten years of earnings and a clear debt position would tell me far more than one quarter. For now, I would put this on my watch list, not in my portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer